Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Tutte le Categorie
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of…
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products.A CHMP positive opinion is one of the final steps before marketing authorization can be granted by the European Commission – a final decision is...
Nasdaq GlobeNewswire
26/04/2024
Lassila & Tikanoja plc: Interim Report 1 January–31 March 2024
Lassila & Tikanoja plcStock exchange release26 April 2024 at 8:00 a.m. Lassila & Tikanoja plc: Interim Report 1 January–31 March 2024STABLE RESULT IN THE FINNISH DIVISIONS – FACILITY SERVICES SWEDEN DID NOT MEET EXPECTATIONS Unless otherwise mentioned, the figures in brackets refer to the corresponding period in the previous year. Net sales for the first quarter were EUR 185.0 million (192.7). Net sales decreased by 4.0%. The decline in net sales was due to the weak...
Nasdaq GlobeNewswire
26/04/2024
Amundi: First Quarter 2024 Results
Amundi: First Quarter 2024 ResultsAssets under management at an all-time high Healthy inflows of +€17bn, net income 1 ,2up +6% Q1/Q1Net income Growth High level of adjusted net income 1 ,2Q1 2024: €318m, +5.9% Q1/Q1 Driven by the growth of net management fees: +4.0% Q1/Q1Combined with cost controlCost-income ratio of 53.3% 2 , at the best level in the industry High & DiversifiedNet inflows Record level...
Nasdaq GlobeNewswire
26/04/2024
Anti-Adhesion Products Market Projected to Reach $1.69 billion by 2030 -…
Anti-adhesion products play a crucial role in modern surgeries by preventing abnormal scar tissue formation between tissues and organs, thus minimizing complications and enhancing recovery. As surgical numbers rise globally, especially in gynecology, abdominal, and cardiovascular areas, the usage of these products is becoming increasingly essential. Challenges include unclear standardization due to varying surgical techniques and the limited efficacy in some cases. Ongoing research and…
PR Newswire
26/04/2024
Valstybės investicinis kapitalas UAB audited Annual information for the year…
Valstybės investicinis kapitalas UAB submits approved Financial Statements for the year 2023, prepared according to the International Financial Reporting Standards as adopted by the European Union, together with the Independent Auditor's Report hereto, as well as the Annual Report. The Company's shareholder decided on the distribution of profit (losses): the Company's net profit of the reporting financial year of EUR 18,809,055 added to the undistributed loss of EUR 20,133,062 from the...
Nasdaq GlobeNewswire
26/04/2024
Identity Governance & Administration Market Projected to Reach $24.42 billion by…
Identity governance and administration (IGA) has emerged as a critical policy-driven approach aimed at fortifying digital identities within organizations, ensuring that proper access is provided to the right individuals for valid reasons. Across the globe, the demand for IGA solutions is on the rise, driven by the need to tackle sophisticated cyber threats, comply with stringent data protection laws, and adapt to the digitization wave sweeping through industries. Challenges include integrating…
PR Newswire
26/04/2024
Contract Research Organization Services Market Projected to Reach $184.21…
The landscape of clinical research services is witnessing a dynamic shift, offering crucial support to the sectors of pharmaceuticals, biotechnology, and medical device industries in their aim to navigate the complicated journey of drug development and market introduction worldwide. These contract research organizations (CROs) are the backbone of medical innovation, providing specialized services, including regulatory submissions, clinical trial management, data analysis, and comprehensive…
PR Newswire
26/04/2024
SUNRATE named one of the top 100 cross-border payment companies for 2024 by FXC…
Businesses can make payments to more than 190 countries and regions, transact in 130+ currencies and settle card spends in more than 15 currencies. They also enjoy global collection services available in over 30 currencies and collect funds in over 10 major global currencies, as if they were local payments. As part of SUNRATE's global vision to drive B2B digitalisation, it also offers effective treasury management tools such as TreasuryOS and RiskOS, to enable businesses to manage and…
PR Newswire
26/04/2024
Hyosung TNC presents a new paradigm through sustainable bio BDO production.
However, traditional BDO production methods have presented notable environmental challenges due to their dependence on fossil fuels as the primary raw material like coal. In response, Hyosung partnered with Geno, a San Diego-based biotech leader specializing in sustainable materials, in 2023. Through Geno's proven plant-based GENO™ BDO technology, which ferments sugars from sugarcane to replace fossil fuels like coal, Hyosung aims to advance its range of regen™ Bio Spandex products. However,...
PR Newswire
26/04/2024
TopSyl: your personalised communication in a can
Sara Mei
26/04/2024
Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of…
Key Takeaways from the Urine Output Monitoring Systems Market Report Key Takeaways from the Urine Output Monitoring Systems Market Report To read more about the latest highlights related to the urine output monitoring systems market, get a snapshot of the key highlights entailed in theGlobal Urine Output Monitoring Systems Market Report Urine Output Monitoring Systems Overview Urine output monitoring systems play a crucial role in healthcare settings, offering real-time...
PR Newswire
25/04/2024
Enghouse Video Partners With SONIFI Health To Deliver Advanced Telehealth…
Enghouse's VidyoRooms solution, a sophisticated video conferencing technology that combines both software and hardware solutions, has been fully integrated into SONIFI Health's interactive TV systems. This integration provides up to 4K high-quality video conferencing, multi-party sessions and robust security features that ensure full compliance with healthcare regulations. Enghouse's VidyoRooms solution, a sophisticated video conferencing technology that combines both software and hardware...
PR Newswire
25/04/2024
LUCARA FIRST QUARTER 2024 RESULTS TO BE RELEASED THURSDAY, MAY 9, 2024
The Company will host a conference call and webcast to discuss the results on Friday, May 10, 2024 at 6:00am Pacific, 9:00am Eastern, 2:00pm UK, 3:00pm CET. The Company will host a conference call and webcast to discuss the results onFriday, May 10, 2024at6:00amPacific,9:00amEastern,2:00pmUK,3:00pm CET. CONFERENCE CALL: To join the conference call please use the following linkhttps://emportal.ink/4arz7Nwor the phone numbers listed below. Conference ID: ...
PR Newswire
25/04/2024
Publication of 2023 Annual Report of Azerion Group N.V.
Amsterdam, 25 April 2024– Azerion announces that it has today published its annual report and audited financial results for the full year 2023 for Azerion Group N.V.. The Annual Report can be found athttps://www.azerion.com/reports/. Contact:Investor
[email protected]
[email protected]
Azerion Founded in 2014, Azerion (EURONEXT: AZRN) is one of Europe's largest digital advertising and entertainment media platforms. Azerion brings global scaled audiences to...
Nasdaq GlobeNewswire
25/04/2024
Tenaris Announces 2024 First Quarter Results
The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Net cash / debt, Free Cash Flow and Operating...
Nasdaq GlobeNewswire
25/04/2024
Markel Group Inc. announces conference call date and time
The webcast, the conference call and the content and permitted replays or rebroadcasts thereof are the exclusive copyrighted property of Markel Group Inc. and may not be copied, taped, rebroadcast, or published in whole or in part without the express written consent of Markel Group Inc. The webcast, the conference call and the content and permitted replays or rebroadcasts thereof are the exclusive copyrighted property of Markel Group Inc. and may not be copied, taped, rebroadcast, or…
PR Newswire
25/04/2024
Millicom (Tigo) Board of Directors Appoints Marcelo Benitez as CEO
Millicom (Tigo) Board of Directors Appoints Marcelo Benitez as CEOLuxembourg, April 25, 2024– Millicom announced today that its Board of Directors has appointed Marcelo Benitez as CEO of Millicom, effective June 1, 2024. Benitez has had a distinguished career with Millicom, having joined the company in Paraguay nearly 30 years ago and risen through the Company's ranks to his most recent role as CEO of TIGO Panama. Benitez's selection completes the final phase of a succession...
Nasdaq GlobeNewswire
25/04/2024
Combined General Meeting of May 16, 2024
Combined General Meeting of May 16, 2024Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “ Company ”), will hold its Combined General Meeting (the “ General Meeting ”) on May 16, 2024, at 10:00 a...
Nasdaq GlobeNewswire
25/04/2024
Mohawk Industries Reports Q1 Results
Commenting on the Company's first quarter results, Chairman and CEO Jeff Lorberbaum stated, “Though economic headwinds are impacting industry sales, margins and mix, our first quarter results reflected the positive effect of actions we are taking to enhance our performance. Our earnings per share rose year over year as a result of restructuring, productivity initiatives and benefits from lower cost raw materials and energy, partially offset by weaker pricing and mix.Across our regions,...
Nasdaq GlobeNewswire
25/04/2024
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year…
Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT),a late-stage biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases, today announced the publication of its 2024 Extra-Financial Performance Report (fiscal year 2023). Third edition of the Extra-Financial Performance report Since 2022, GENFIT has published a detailed Extra-Financial Performance report in...
Nasdaq GlobeNewswire
25/04/2024
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar…
CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA ®CAMBRIDGE, Mass., April25, 2024(GLOBE NEWSWIRE) --BiogenInc. (Nasdaq: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for TOFIDENCE™ (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA ®1. The intravenous...
Nasdaq GlobeNewswire
25/04/2024
Aon completes acquisition of NFP to bring more capability to clients
– Enterprise value of $13.0 billion, including $7.0 billion cash and assumed liabilities as well as $6.0 billion in equity in the form of 19.0 million Aon shares – Enterprise value of$13.0 billion, including$7.0 billioncash and assumed liabilities as well as$6.0 billionin equity in the form of 19.0 million Aon shares DUBLIN,April 25, 2024/PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, announced today that it has completed the...
PR Newswire
25/04/2024
WillScot Mobile Mini Announces Investor Conference Schedule for May and June…
Oppenheimer Industrial Growth ConferenceDate: May 6, 2024 Location: Virtual Barclays Americas Select Franchise ConferenceDate: May 7 - 8, 2024 Location: London, UK Bank of America Transportation, Airlines, and Industrials ConferenceDate: May 15, 2024 Location: New York, NY William Blair Growth Stock ConferenceDate: June 4, 2024 Location: Chicago, IL Stifel Cross Sector InsightsDate: June 4, 2024 Location: Boston, MA Baird Global Consumer, Tech & Services...
Nasdaq GlobeNewswire
25/04/2024
Armenian Political Prisoner, Ruben Vardanyan, Granted Permission to Speak With…
The strike began on April 5, 2024, after requests were repeatedly ignored for a fair and transparent trial to be held in a timely manner in line with international legal standards. His trial was originally slated for January, but then extended to May without cause. The strike began onApril 5, 2024, after requests were repeatedly ignored for a fair and transparent trial to be held in a timely manner in line with international legal standards. His trial was originally slated for January, but...
PR Newswire
25/04/2024
Altri Comunicati